EDX — Edx Medical Cashflow Statement
0.000.00%
Last trade - 00:00- £36.04m
- £33.20m
- £0.33m
Annual cashflow statement for Edx Medical, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2022 March 31st | C2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.253 | -3.71 | -3.77 | -3.72 | -5.84 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | — | 1 | 0.54 | -0.52 | 0.218 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.045 | 1.15 | -0.209 | 0.49 | 0.944 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -0.208 | -1.28 | -3.18 | -3.47 | -4.37 |
| Capital Expenditures | -0.001 | — | -0.013 | -0.204 | -0.194 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.097 | 0.217 | 0.042 | 0.006 |
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.001 | 0.097 | 0.204 | -0.162 | -0.188 |
| Financing Cash Flow Items | -0.064 | 0.271 | -0.08 | -0.191 | -0.319 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.24 | 1.3 | 6.93 | 1.96 | 5.07 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 1.03 | 0.116 | 3.95 | -1.67 | 0.513 |